| - GRCh37:
- Chr6:43016295
- GRCh38:
- Chr6:43048557
| CUL7 | P613fs, P645fs | 3M syndrome 1 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr6:43017696-43017707
- GRCh38:
- Chr6:43049958-43049969
| CUL7 | | 3M syndrome 1 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr6:43006127
- GRCh38:
- Chr6:43038389
| CUL7 | Q1550*, Q1551*, Q1555*, Q1583* | 3M syndrome 1 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr6:43008444
- GRCh38:
- Chr6:43040706
| CUL7 | W1282R, W1283R, W1315R | 3M syndrome 1 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr6:43010905-43010906
- GRCh38:
- Chr6:43043167-43043168
| CUL7 | R1122fs, R1123fs, R1155fs | 3M syndrome 1 | Likely pathogenic (Jun 8, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43017625
- GRCh38:
- Chr6:43049887
| CUL7 | | 3M syndrome 1 | Uncertain significance (Oct 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43005493-43005494
- GRCh38:
- Chr6:43037755-43037756
| CUL7 | Q1676fs, Q1677fs, Q1681fs, Q1709fs | 3M syndrome 1 | Uncertain significance (Sep 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43013324
- GRCh38:
- Chr6:43045586
| CUL7 | | 3M syndrome 1 | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43015904-43015905
- GRCh38:
- Chr6:43048166-43048167
| CUL7 | N719fs, N751fs | 3M syndrome 1 | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43013725-43013729
- GRCh38:
- Chr6:43045987-43045991
| CUL7 | N921fs, N953fs | 3M syndrome 1 | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43011294
- GRCh38:
- Chr6:43043556
| CUL7 | Q1083fs, Q1115fs | 3M syndrome 1 | Likely pathogenic (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43006723
- GRCh38:
- Chr6:43038985
| CUL7 | Q1432*, Q1433*, Q1465* | 3M syndrome 1 | Pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43013323
- GRCh38:
- Chr6:43045585
| CUL7 | | 3M syndrome 1 | Likely pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43008389
- GRCh38:
- Chr6:43040651
| CUL7 | P1300R, P1301R, P1333R | 3M syndrome 1 | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43012601
- GRCh38:
- Chr6:43044863
| CUL7 | E1021K, E1053K | 3M syndrome 1 | Likely pathogenic (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43011246
- GRCh38:
- Chr6:43043508
| CUL7 | L1099fs, L1131fs | 3M syndrome 1 | Likely pathogenic (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43014785
- GRCh38:
- Chr6:43047047
| CUL7 | V776M, V744M | not provided, 3M syndrome 1 | Uncertain significance (Mar 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43008396
- GRCh38:
- Chr6:43040658
| CUL7 | R1298C, R1299C, R1331C | 3M syndrome 1 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr6:43005675
- GRCh38:
- Chr6:43037937
| CUL7 | C1615*, C1616*, C1620*, C1648* | 3M syndrome 1 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr6:43015992
- GRCh38:
- Chr6:43048254
| CUL7 | | 3M syndrome 1 | Pathogenic (Sep 17, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr6:43008114
- GRCh38:
- Chr6:43040376
| CUL7 | E1357D, E1358D, E1390D | not provided, 3M syndrome 1 | Uncertain significance (Mar 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43019899
- GRCh38:
- Chr6:43052161
| CUL7 | R210W | 3M syndrome 1 | Uncertain significance (Jul 27, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43005482
- GRCh38:
- Chr6:43037744
| CUL7 | R1713G, R1681G, R1685G, R1680G | 3M syndrome 1 | Uncertain significance (Aug 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43006367
- GRCh38:
- Chr6:43038629
| CUL7 | I1534F, I1501F, I1502F | 3M syndrome 1 | Uncertain significance (Jan 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43014634
- GRCh38:
- Chr6:43046896
| CUL7 | L826R, L794R | 3M syndrome 1 | Uncertain significance (Jan 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43006005-43006008
- GRCh38:
- Chr6:43038267-43038270
| CUL7 | C1589fs, C1590fs, C1594fs, C1622fs | 3M syndrome 1 | Pathogenic (Mar 10, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr6:43014815
- GRCh38:
- Chr6:43047077
| CUL7 | R734C, R766C | 3M syndrome 1, not provided | Uncertain significance (Jun 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43006015
- Chr6:43012533
- GRCh38:
- Chr6:43038277
- Chr6:43044795
| CUL7, CUL7 | L1587P, L1588P, L1592P, L1620P, W1043*, W1075* | 3M syndrome 1 | Pathogenic (May 31, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:43015891
- Chr6:43005611-43005612
- GRCh38:
- Chr6:43048153
- Chr6:43037873-43037874
| CUL7, CUL7 | R722*, R754*, D1637*, D1638*, D1642*, D1670* | 3M syndrome 1 | Pathogenic (May 31, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:43006015
- GRCh38:
- Chr6:43038277
| CUL7 | L1587P, L1588P, L1592P, L1620P | 3-M syndrome, not provided | Conflicting interpretations of pathogenicity (Feb 16, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:43013038
- GRCh38:
- Chr6:43045300
| CUL7 | Y1021D, Y989D | 3M syndrome 1 | Likely pathogenic (Nov 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43018939
- GRCh38:
- Chr6:43051201
| CUL7 | Q334K, Q366K | 3M syndrome 1 | Uncertain significance (Mar 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43020108-43020109
- GRCh38:
- Chr6:43052370-43052371
| CUL7 | T140fs | 3M syndrome 1 | Pathogenic (Jun 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43020467
- GRCh38:
- Chr6:43052729
| CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43020387
- GRCh38:
- Chr6:43052649
| CUL7 | R47L | not provided, Inborn genetic diseases, 3M syndrome 1
| Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43020314
- GRCh38:
- Chr6:43052576
| CUL7 | K71N | 3M syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43017281
- GRCh38:
- Chr6:43049543
| CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43017221
- GRCh38:
- Chr6:43049483
| CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43017217
- GRCh38:
- Chr6:43049479
| CUL7 | A585T, A617T | not provided, 3M syndrome 1 | Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43013369
- GRCh38:
- Chr6:43045631
| CUL7 | R972C, R940C | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43013368
- GRCh38:
- Chr6:43045630
| CUL7 | R940H, R972H | not provided, 3M syndrome 1 | Uncertain significance (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43012582
- GRCh38:
- Chr6:43044844
| CUL7 | R1027H, R1059H | not provided, 3M syndrome 1 | Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43006603
- GRCh38:
- Chr6:43038865
| CUL7 | | not provided, 3M syndrome 1 | Conflicting interpretations of pathogenicity (Feb 26, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:43006567
- GRCh38:
- Chr6:43038829
| CUL7 | | not provided, 3M syndrome 1 | Conflicting interpretations of pathogenicity (Sep 4, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:43006208
- GRCh38:
- Chr6:43038470
| CUL7 | V1524I, V1556I, V1523I, V1528I | 3M syndrome 1, not provided | Uncertain significance (Aug 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43006173
- GRCh38:
- Chr6:43038435
| CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43006171
- GRCh38:
- Chr6:43038433
| CUL7 | S1535L, S1540L, S1568L, S1536L | 3M syndrome 1 | Uncertain significance (Aug 22, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43005700
- GRCh38:
- Chr6:43037962
| CUL7 | S1607N, S1612N, S1640N, S1608N | not provided, 3M syndrome 1 | Uncertain significance (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43020259
- GRCh38:
- Chr6:43052521
| CUL7 | G90R | not provided, 3M syndrome 1 | Uncertain significance (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43017147
- GRCh38:
- Chr6:43049409
| CUL7 | E608G, E640G | not provided, 3M syndrome 1 | Conflicting interpretations of pathogenicity (Aug 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:43016266
- GRCh38:
- Chr6:43048528
| CUL7 | R623C, R655C | not provided, 3M syndrome 1 | Uncertain significance (Sep 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43011357
- GRCh38:
- Chr6:43043619
| CUL7 | I1094V, I1062V | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43011258
- GRCh38:
- Chr6:43043520
| CUL7 | R1095C, R1127C | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43011257
- GRCh38:
- Chr6:43043519
| CUL7 | R1127H, R1095H | not provided, 3M syndrome 1 | Uncertain significance (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43010737
- GRCh38:
- Chr6:43042999
| CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43019172
- GRCh38:
- Chr6:43051434
| CUL7 | R288Q, R256Q | not provided, 3M syndrome 1 | Uncertain significance (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43019073
- GRCh38:
- Chr6:43051335
| CUL7 | R321T, R289T | not provided, 3M syndrome 1 | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43014655
- GRCh38:
- Chr6:43046917
| CUL7 | R787H, R819H | not provided, 3M syndrome 1 | Uncertain significance (Jun 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43010694
- GRCh38:
- Chr6:43042956
| CUL7 | R1163Q, R1164Q, R1196Q | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43010580
- GRCh38:
- Chr6:43042842
| CUL7 | A1201V, A1234V, A1202V | not provided, 3M syndrome 1 | Uncertain significance (Sep 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43005551
- GRCh38:
- Chr6:43037813
| CUL7 | E1658K, E1690K, E1662K, E1657K | 3M syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43005430
- GRCh38:
- Chr6:43037692
| CUL7 | R1702Q, R1730Q, R1697Q, R1698Q | not provided, 3M syndrome 1 | Uncertain significance (Aug 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43021557
- GRCh38:
- Chr6:43053819
| CUL7, LOC129996487 | | 3M syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43021537
- GRCh38:
- Chr6:43053799
| LOC129996487, CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43018838
- GRCh38:
- Chr6:43051100
| CUL7 | | 3M syndrome 1 | Uncertain significance (Mar 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43018774
- GRCh38:
- Chr6:43051036
| CUL7 | Y389H, Y421H | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43017853
- GRCh38:
- Chr6:43050115
| CUL7 | V473M, V505M | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43017813
- GRCh38:
- Chr6:43050075
| CUL7 | C518Y, C486Y | not provided, 3M syndrome 1 | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43014051
- GRCh38:
- Chr6:43046313
| CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43014022
- GRCh38:
- Chr6:43046284
| CUL7 | A871V, A903V | not provided, 3M syndrome 1 | Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43013736
- GRCh38:
- Chr6:43045998
| CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43008153
- GRCh38:
- Chr6:43040415
| CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43008129
- GRCh38:
- Chr6:43040391
| CUL7 | | 3M syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43008119
- GRCh38:
- Chr6:43040381
| CUL7 | E1357K, E1356K, E1389K | 3M syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43013015
- GRCh38:
- Chr6:43045277
| CUL7 | W996*, W1028* | 3M syndrome 1 | Pathogenic (Feb 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43019430
- GRCh38:
- Chr6:43051692
| CUL7 | R218fs, R250fs | 3M syndrome 1 | Pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43018795
- GRCh38:
- Chr6:43051057
| CUL7 | R414*, R382* | not provided | Pathogenic (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43008709-43008710
- GRCh38:
- Chr6:43040971-43040972
| CUL7 | V1251fs, V1252fs, V1284fs | 3M syndrome 1 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr6:43020101
- GRCh38:
- Chr6:43052363
| CUL7 | | not provided, 3M syndrome 1 | Conflicting interpretations of pathogenicity (Mar 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:43008376
- GRCh38:
- Chr6:43040638
| CUL7 | | not provided, 3M syndrome 1 | Conflicting interpretations of pathogenicity (Aug 31, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:43007927
- GRCh38:
- Chr6:43040189
| CUL7 | T1420A, T1421A, T1453A | not provided, 3M syndrome 1 | Benign (Sep 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43016151
- GRCh38:
- Chr6:43048413
| CUL7 | R693Q, R661Q | not provided, 3M syndrome 1 | Benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43014053
- GRCh38:
- Chr6:43046315
| CUL7 | P861S, P893S | not provided, not specified, 3M syndrome 1
| Conflicting interpretations of pathogenicity (May 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:43013398-43013420
- GRCh38:
- Chr6:43045660-43045682
| CUL7 | | 3M syndrome 1 | Uncertain significance (Oct 2, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43014303
- GRCh38:
- Chr6:43046565
| CUL7 | H812Y, H844Y | 3M syndrome 1 | Uncertain significance (Dec 30, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr6:43006614
- GRCh38:
- Chr6:43038876
| CUL7 | Q1469R, Q1468R, Q1501R | 3M syndrome 1 | Uncertain significance (Dec 30, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr6:43012573
- GRCh38:
- Chr6:43044835
| CUL7 | P1030fs, P1062fs | 3M syndrome 1 | Likely pathogenic (Sep 4, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr6:43008073
- GRCh38:
- Chr6:43040335
| CUL7 | E1372fs, E1371fs, E1404fs | 3M syndrome 1 | Likely pathogenic (Oct 7, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr2:220432933-220432934
- GRCh38:
- Chr2:219568211-219568212
| OBSL1 | E376* | 3M syndrome 2, 3M syndrome 1 | Pathogenic/Likely pathogenic (Jan 4, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr2:220432872
- GRCh38:
- Chr2:219568150
| OBSL1 | R396H | 3M syndrome 1 | Likely pathogenic (Dec 18, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr2:220432772-220432782
- GRCh38:
- Chr2:219568050-219568060
| OBSL1 | | 3M syndrome 1 | Likely pathogenic (Jan 4, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr6:43020320-43020321
- GRCh38:
- Chr6:43052582-43052583
| CUL7 | M69fs | 3M syndrome 1 | Likely pathogenic (Aug 27, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr6:43017788
- GRCh38:
- Chr6:43050050
| CUL7 | W494*, W526* | 3M syndrome 1 | Likely pathogenic (Mar 14, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr6:43008774
- GRCh38:
- Chr6:43041036
| CUL7 | Q1229*, Q1228*, Q1261* | 3M syndrome 1 | Likely pathogenic (Oct 10, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr6:43020018
- GRCh38:
- Chr6:43052280
| CUL7 | L170W | Inborn genetic diseases, not provided, 3M syndrome 1
| Uncertain significance (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43008060-43008062
- GRCh38:
- Chr6:43040322-43040324
| CUL7 | E1376del, E1375del, E1408del | 3M syndrome 1, not provided | Uncertain significance (Aug 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43017322
- GRCh38:
- Chr6:43049584
| CUL7 | R550*, R634*, R582* | not provided, 3M syndrome 1 | Pathogenic (Nov 22, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43019017
- GRCh38:
- Chr6:43051279
| CUL7 | V308L, V340L | not provided, 3M syndrome 1 | Uncertain significance (Sep 16, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:43021651
- GRCh38:
- Chr6:43053913
| CUL7, LOC129996487 | | 3M syndrome 1 | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:43021649
- GRCh38:
- Chr6:43053911
| CUL7, LOC129996487 | | 3M syndrome 1 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |